ID

39899

Description

Presentations of Hyperandrogenic Phenotypes in Taiwanese Women; ODM derived from: https://clinicaltrials.gov/show/NCT01940666

Lien

https://clinicaltrials.gov/show/NCT01940666

Mots-clés

  1. 02/03/2020 02/03/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

2 mars 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hyperandrogenism, NCT01940666

Eligibility Hyperandrogenism, NCT01940666

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
hyperandrogenic women who were classified into four groups:
Description

Gender Hyperandrogenism

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0206081
total testosterone (tt),
Description

Total Testosterone Measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0202227
androstenedione (a4),
Description

Androstenedione

Type de données

boolean

Alias
UMLS CUI [1]
C0002860
free androgen index (fai),
Description

FAI - Free androgen index measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0428629
and dehydroepiandrosterone sulphate(dhea-s).
Description

Dehydroepiandrosterone Sulfate

Type de données

boolean

Alias
UMLS CUI [1]
C0057277
according to abnormally elevated androgen measures each above its cut-off value, and non hyperandrogenic women (who had all androgens below their cut-off values)
Description

Increased androgen level | Androgen level Cutoff Value | Gender Without Hyperandrogenism

Type de données

boolean

Alias
UMLS CUI [1]
C1295651
UMLS CUI [2,1]
C0919646
UMLS CUI [2,2]
C1442160
UMLS CUI [2,3]
C1522609
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0332288
UMLS CUI [3,3]
C0206081
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
none of the women studied had
Description

Exclusion Criteria Fulfill

Type de données

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1550543
hypogonadotropic hypogondism,
Description

Hypogonadotropic hypogonadism

Type de données

boolean

Alias
UMLS CUI [1]
C0271623
hyperprolactinemia,
Description

Hyperprolactinemia

Type de données

boolean

Alias
UMLS CUI [1]
C0020514
congenital adrenal hyperplasia,
Description

Congenital adrenal hyperplasia

Type de données

boolean

Alias
UMLS CUI [1]
C0001627
premature ovarian failure,
Description

Premature Menopause

Type de données

boolean

Alias
UMLS CUI [1]
C0025322
androgen-secreting tumors,
Description

Tumors Androgen secretion

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C3271399
cushing's syndrome,
Description

Cushing Syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0010481
or any other endocrine or systemic disease that may affect the reproductive function,
Description

Endocrine System Disease Affecting Reproductive function | Systemic disease Affecting Reproductive function

Type de données

boolean

Alias
UMLS CUI [1,1]
C0014130
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0232896
UMLS CUI [2,1]
C0442893
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0232896
or any disorders of the uterus (e.g. asherman's syndrome and mullerian genesis) and chromosomal anomalies (e.g. turner's syndrome).
Description

Uterine Diseases | Asherman Syndrome | Mullerian agenesis | Congenital chromosomal disease | Turner Syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0042131
UMLS CUI [2]
C0156372
UMLS CUI [3]
C4230168
UMLS CUI [4]
C0008626
UMLS CUI [5]
C0041408
in addition, we excluded females who had
Description

Exclusion Criteria Additional

Type de données

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1524062
experienced menarche less than three years preceding the study start,
Description

Menarche Recent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0025274
UMLS CUI [1,2]
C0332185
or who had day 3 fsh > 15 miu/ml, as well as women with insufficient clinical/biochemical records,
Description

Follicle stimulating hormone measurement | Gender Medical Records Insufficient

Type de données

boolean

Alias
UMLS CUI [1]
C0202022
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0025102
UMLS CUI [2,3]
C0231180
and women with ovarian cysts or tumors in an ultrasonographic examination.
Description

Ovarian Cysts Ultrasonography | Ovarian neoplasm Ultrasonography

Type de données

boolean

Alias
UMLS CUI [1,1]
C0029927
UMLS CUI [1,2]
C0041618
UMLS CUI [2,1]
C0919267
UMLS CUI [2,2]
C0041618

Similar models

Eligibility Hyperandrogenism, NCT01940666

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Gender Hyperandrogenism
Item
hyperandrogenic women who were classified into four groups:
boolean
C0079399 (UMLS CUI [1,1])
C0206081 (UMLS CUI [1,2])
Total Testosterone Measurement
Item
total testosterone (tt),
boolean
C0202227 (UMLS CUI [1])
Androstenedione
Item
androstenedione (a4),
boolean
C0002860 (UMLS CUI [1])
FAI - Free androgen index measurement
Item
free androgen index (fai),
boolean
C0428629 (UMLS CUI [1])
Dehydroepiandrosterone Sulfate
Item
and dehydroepiandrosterone sulphate(dhea-s).
boolean
C0057277 (UMLS CUI [1])
Increased androgen level | Androgen level Cutoff Value | Gender Without Hyperandrogenism
Item
according to abnormally elevated androgen measures each above its cut-off value, and non hyperandrogenic women (who had all androgens below their cut-off values)
boolean
C1295651 (UMLS CUI [1])
C0919646 (UMLS CUI [2,1])
C1442160 (UMLS CUI [2,2])
C1522609 (UMLS CUI [2,3])
C0079399 (UMLS CUI [3,1])
C0332288 (UMLS CUI [3,2])
C0206081 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Exclusion Criteria Fulfill
Item
none of the women studied had
boolean
C0680251 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Hypogonadotropic hypogonadism
Item
hypogonadotropic hypogondism,
boolean
C0271623 (UMLS CUI [1])
Hyperprolactinemia
Item
hyperprolactinemia,
boolean
C0020514 (UMLS CUI [1])
Congenital adrenal hyperplasia
Item
congenital adrenal hyperplasia,
boolean
C0001627 (UMLS CUI [1])
Premature Menopause
Item
premature ovarian failure,
boolean
C0025322 (UMLS CUI [1])
Tumors Androgen secretion
Item
androgen-secreting tumors,
boolean
C0027651 (UMLS CUI [1,1])
C3271399 (UMLS CUI [1,2])
Cushing Syndrome
Item
cushing's syndrome,
boolean
C0010481 (UMLS CUI [1])
Endocrine System Disease Affecting Reproductive function | Systemic disease Affecting Reproductive function
Item
or any other endocrine or systemic disease that may affect the reproductive function,
boolean
C0014130 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0232896 (UMLS CUI [1,3])
C0442893 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0232896 (UMLS CUI [2,3])
Uterine Diseases | Asherman Syndrome | Mullerian agenesis | Congenital chromosomal disease | Turner Syndrome
Item
or any disorders of the uterus (e.g. asherman's syndrome and mullerian genesis) and chromosomal anomalies (e.g. turner's syndrome).
boolean
C0042131 (UMLS CUI [1])
C0156372 (UMLS CUI [2])
C4230168 (UMLS CUI [3])
C0008626 (UMLS CUI [4])
C0041408 (UMLS CUI [5])
Exclusion Criteria Additional
Item
in addition, we excluded females who had
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Menarche Recent
Item
experienced menarche less than three years preceding the study start,
boolean
C0025274 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Follicle stimulating hormone measurement | Gender Medical Records Insufficient
Item
or who had day 3 fsh > 15 miu/ml, as well as women with insufficient clinical/biochemical records,
boolean
C0202022 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C0025102 (UMLS CUI [2,2])
C0231180 (UMLS CUI [2,3])
Ovarian Cysts Ultrasonography | Ovarian neoplasm Ultrasonography
Item
and women with ovarian cysts or tumors in an ultrasonographic examination.
boolean
C0029927 (UMLS CUI [1,1])
C0041618 (UMLS CUI [1,2])
C0919267 (UMLS CUI [2,1])
C0041618 (UMLS CUI [2,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial